Balance Sheet
Cash Flow Statement
Amortizatization of IntangiblesCapital ExpendituresCash from Discontinued OperationsCash from Financing ActivitiesCash from Investing ActivitiesCash from OperationsChange in Account PayablesChange in Accured ExpensesChange in CashDepreciation & Amortization (CF)Depreciation and DepletionExchange Rate EffectFree Cash FlowGains from Investment SecuritiesNet Cash FlowNet IncomeNon-cash ItemsOther Working Capital ChangesShare-based Compensation
Daily Values
Growth Metrics
Income Statement
Others
Ratios

Nukkleus (NUKK) Gains from Investment Securities (2022 - 2025)

Historic Gains from Investment Securities for Nukkleus (NUKK) over the last 4 years, with Q2 2025 value amounting to -$5.1 million.

  • Nukkleus' Gains from Investment Securities fell 422558.45% to -$5.1 million in Q2 2025 from the same period last year, while for Jun 2025 it was -$11.5 million, marking a year-over-year decrease of 938600.57%. This contributed to the annual value of $15538.0 for FY2023, which is 9070.38% down from last year.
  • Nukkleus' Gains from Investment Securities amounted to -$5.1 million in Q2 2025, which was down 422558.45% from $104823.0 recorded in Q1 2025.
  • Over the past 5 years, Nukkleus' Gains from Investment Securities peaked at $124286.0 during Q4 2023, and registered a low of -$6.5 million during Q1 2022.
  • Over the past 4 years, Nukkleus' median Gains from Investment Securities value was $105503.5 (recorded in 2022), while the average stood at -$1.4 million.
  • Within the past 5 years, the most significant YoY rise in Nukkleus' Gains from Investment Securities was 1565.98% (2025), while the steepest drop was 422558.45% (2025).
  • Quarter analysis of 4 years shows Nukkleus' Gains from Investment Securities stood at $106184.0 in 2022, then rose by 17.05% to $124286.0 in 2023, then changed by 0.0% to $124286.0 in 2024, then plummeted by 4225.58% to -$5.1 million in 2025.
  • Its last three reported values are -$5.1 million in Q2 2025, $104823.0 for Q1 2025, and $124286.0 during Q2 2024.